A003850 Stock Overview
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for A003850 from our risk checks.
Boryung Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,850.00 |
| 52 Week High | ₩13,750.00 |
| 52 Week Low | ₩8,720.00 |
| Beta | 0.65 |
| 11 Month Change | 12.00% |
| 3 Month Change | 14.60% |
| 1 Year Change | 31.08% |
| 33 Year Change | -30.70% |
| 5 Year Change | 27.14% |
| Change since IPO | 1,860.19% |
Recent News & Updates
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06Recent updates
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Shareholder Returns
| A003850 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 7.7% | 6.8% | -1.0% |
| 1Y | 31.1% | 23.1% | 1.0% |
Return vs Industry: A003850 exceeded the KR Pharmaceuticals industry which returned 23.1% over the past year.
Return vs Market: A003850 exceeded the KR Market which returned 1% over the past year.
Price Volatility
| A003850 volatility | |
|---|---|
| A003850 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A003850 has not had significant price volatility in the past 3 months.
Volatility Over Time: A003850's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 1,403 | Jay Kim | www.boryung.co.kr |
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd.
Boryung Corporation Fundamentals Summary
| A003850 fundamental statistics | |
|---|---|
| Market cap | ₩786.92b |
| Earnings (TTM) | ₩64.58b |
| Revenue (TTM) | ₩928.72b |
12.2x
P/E Ratio0.8x
P/S RatioIs A003850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003850 income statement (TTM) | |
|---|---|
| Revenue | ₩928.72b |
| Cost of Revenue | ₩560.10b |
| Gross Profit | ₩368.61b |
| Other Expenses | ₩304.04b |
| Earnings | ₩64.58b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 972.47 |
| Gross Margin | 39.69% |
| Net Profit Margin | 6.95% |
| Debt/Equity Ratio | 34.4% |
How did A003850 perform over the long term?
See historical performance and comparison